Health Promotion and Disease Prevention Flashcards
1
Q
Hepatitis B (Trmt)
A
- Routine testing for HBsAG not needed; only for those @ high risk & poor immune response
- Boosters for dialysis, those with levels less than 10 mIU/mL
- Post exposure prophylaxis prevents
2
Q
Hepatitis B (Patho)
A
- Transmitted thru exchange of blood/body fluids
- Vaccine - not a live virus; not for those with anaphylactic rxn to baker’s yeast; 3 doses with at lease 8 wks b/w 2nd and 3rd (series does not need to be repeated if 3rd dose delayed)
- Can lead to liver failure, hematoma, carcinoma, cirrhosis
- All preg women should be screened for HBsAG
3
Q
Smallpox (Patho)
A
- Direct deposit of infective droplets onto the nasal, oral, or pharyngeal mucosal membrane; prolonged face-to-face contact
- Most contagious with onset of rash; until last scab falls off; Incubation 7-17 days
- S/S=fever, malaise, HA, body aches, poss vomit
- Rash-small red spots on tongue/mouth to face, arms, legs, hands, and then feet; same stage
4
Q
Smallpox (Trmt)
A
- Supportive; Isolation
- Vaccination w/in 3 days of exposure reduces severity; after 4-7 days some protection from disease
- Live vaccine (vaccinia) - red, itchy bump in 3-4 days; lrg draining pustule then scab - shed virus until scab off
- Rxn - sore, body aches, poss fever
5
Q
VZV (Info)
A
- Vesicular lesions, fever, itch, fatigue
- Natural infection - lifetime immunity
- Greatest mortality rate in 30-49 yo
- Confirm immunity through titers esp for healthcare workers
6
Q
VZV vaccination
A
- Birth and repeat b/w 4-6 yrs
- Older - 2 shots 4-8 wks apart
- Pregnancy - after birth, 4-8 wks later
- May experience mild pox
- Exposure - w/in 3-5 days
- VZIG for those at risk with contraind for vaccine - pooled blood that is safe
7
Q
Live attenuated vaccines
A
Look up
8
Q
Tetanus
A
- Found in soil
- Painful muscle weakness, spasm
- 3 vaccine injections with boosters every 10 yrs
- Td for primary series and boosters in adults (one may be Tdap); Child - Tdap
- Rxn - redness and warmth
- TIG if unclean wound and unknown vaccine
9
Q
Hepatitis A
A
- Fecal-oral route
- US - 50% have no cause
- Risk factors - men with men, illegal drugs, international travel
- Peak infectivity during 2 wks before jaundice
- Inactivate - heat/cook foods, disinfecting
- Coinfection with Hep B or C can lead to decline
10
Q
Hepatitis A vaccine
A
- Those with Hep B or C or any chronic liver disease
- Those with clotting factor disorders and are receiving clotting factor concentrates
- Not live virus
- 4-6 wks prior to travel
11
Q
Hepatitis A vaccine
A
- Havrix - 2 dose at 0 and 6-12 mos
- Vaqta - 2 dose at 0 and 6-18 mos
- Twinrix - 3 dose at 0, 1, 6 mos or 4 dose at 0, 7, 21-30 mos followed by booster at mos 12
- HAV IG may be given w/in 2 wks to minimize risk of infection
12
Q
Stages of Change Model/
Transtheoretical Model
A
- Precontemplation
- Contemplation
- Preparation
- Action
- Maintenance/relapse